European Pharmaceutical Review

APRIL 11, 2024

Pharma within planetary boundaries One area lacking major gains is in the process of design, engineering, commissioning and maintaining a manufacturing plant itself. Creating more sustainable business processes is a pre-competitive activity; we all win when we make progress in sustainability and lose if we don’t.

92

92

pharmaphorum

JUNE 8, 2022

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). ” Lawmakers are also getting involved.

Independent Pharmacies 64

Independent Pharmacies 64

ISPE

AUGUST 17, 2023

Current digital validation limitations Although automation has made notable advancements in our manufacturing processes over the past decade, there are still mundane tasks within the design, commissioning, qualification, and validation phases of projects that will benefit from becoming more streamlined and efficient.

Documentation 98

Documentation 98

pharmaphorum

JULY 22, 2022

Earlier this year, the company passed a significant milestone in its health business after it made its telehealth platform Amazon Care available to employers nationwide in the US, and with its in-person services rolling out in dozens of cities across the country.

105

105

Pharmaceutical Technology

OCTOBER 28, 2022

There, the business plans to submit an IND application for a Phase I/II in the second half of 2023, with a readout in 2024. Competition in an increasingly heated market. Vaxcyte’s recent clinical success brings further competition into a sector, which is becoming increasingly heated.

Vaccines 64

Vaccines FDA Immunization 64

pharmaphorum

APRIL 23, 2021

NHSX is far from the only body to be considering the ethical implications of AI and just this week the European Commission (EC) releasing its final proposal for an Artificial Intelligence Act. Ethics: An ongoing dialogue.

FDA 131

FDA 131

pharmaphorum

JANUARY 17, 2022

The case was brought by the US Federal Trade Commission (FTC) and US states New York, California, Illinois, North Carolina, Ohio, Pennsylvania and Virginia, for Shkreli’s actions that blocked any competition with its key medicine to preserve monopoly profits.

Immunization 45

Immunization 45

pharmaphorum

AUGUST 27, 2020

GlaxoSmithKline has approval on both sides of the Atlantic for its multiple myeloma drug Blenrep, after getting the nod from the European Commission. billion takeover of Tesaro.

FDA 64

FDA Labelling 64

European Pharmaceutical Review

NOVEMBER 8, 2022

3 This same bill also requires the FDA to establish procedures for referring such petitions to the US Federal Trade Commission (FTC) as an anticompetitive business practice. 2873 (“Affordable Prescriptions for Patients Through Promoting Competition Act of 2021”), [link] gov/bill/117th-congress/house-bill/2873/text; H.R.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

SEPTEMBER 13, 2023

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.

Communication 73

Communication Documentation 73

European Pharmaceutical Review

SEPTEMBER 14, 2023

A new proposal , ‘Business in Europe: Framework for Income Taxation’ (BEFIT), from European Commission (EC) introduces a simpler, single set of rules to determine the tax base of groups of companies. According to the EC, the new rules could reduce tax compliance costs for businesses operating in the EU by up to 65 percent.

Packaging 74

Packaging 74

European Pharmaceutical Review

FEBRUARY 2, 2023

The European Commission (EC) conducted a comprehensive assessment 1 in 2021 that revealed that 80 percent of API by volume imported into Europe comes from just five countries, with China supplying 45 percent of the API and the rest coming from India, Indonesia, US and UK.

Generic Medicine 99

Generic Medicine Packaging Documentation Pharmaceutical Companies 99

European Pharmaceutical Review

FEBRUARY 7, 2023

Some of the current and anticipated proposals will not be adopted in 2023, or even before the end of tenure of the current European Commission in late 2024. Following publication of the proposal, the European Commission launched an eight-week public consultation. However, those proposals that are adopted could have wide-ranging impact.

Packaging 93

Packaging 93

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe.

FDA 111

FDA 111

The Nontraditional Pharmacist

NOVEMBER 20, 2019

Some of the links on this website are affiliate links, which means that if you choose to make a purchase, we will earn a commission. This commission comes at no additional cost to you. Please do not spend any money on these products unless you feel you need them or that they will help you achieve your goals. .”

Communication 52

Communication 52

BuzzRx

FEBRUARY 15, 2023

Also, it is illegal, and the Federal Trade Commission regularly tracks down and prosecutes such overseas retailers. Many online retailers offer free shipping, but most take at least 5-7 business days to ship the contacts to you after they have verified your prescription. However, buying contacts from these websites is not recommended.

Insurance 52

Insurance Customer Service 52

European Pharmaceutical Review

JULY 1, 2022

This evolving focus is clearly visible in the growing emphasis now placed by many global businesses on environmental, social and governance (ESG) issues – and especially the ‘social’ element. ESG is an umbrella term for the tools used to measure the sustainability and ethical impact of a business.

Pharmaceutical Companies 84

Pharmaceutical Companies Pharmaceutical Companies Documentation 84

ISPE

NOVEMBER 10, 2022

In the last 5 years, there is suddenly a lot of competition and new entrants to cell therapy, but so far no one can dominate the market and everyone is still working on solving the basic quality and manufacturing issues and complications. When you look at the cell and gene industry today, what’s most surprising to you?

Documentation 98

Documentation Compounding Hospitals Immunization 98

ISPE

MAY 9, 2023

These areas raise the question: How does an area become a hub for competing businesses? Government and business leaders came together with a plan to meet these challenges and, in 1959, created Research Triangle Park (RTP). Every year we encourage new entrepreneurs through our policies and grants for small businesses.”

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

pharmaphorum

DECEMBER 9, 2020

The government said today that 98% of GB businesses exported to NI will not face any tariffs, and items shiped into the EU via NI will also largely be expempot from levies. UK Prime Minster Boris Johnson is scheduled to meet with EU Commission President Ursula von der Leyen this evening to try to make a breakthrough in the talks.

97

97

Omnicell

JANUARY 10, 2023

The EO contends that a lack of competition increases prices and reduces access to quality care. In this most recent EO, the President targeted not one, but three of the largest sectors of healthcare—hospitals, health plans, and pharmaceutical companies. Following are summaries of the specific proposals in the EO for the three areas.

Hospitals 52

Hospitals Omnicell Insurance Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. These actions allegedly led to the extension of Novartis’ patents.

Documentation 97

Documentation FDA Hospitals Dosage 97

Pharmaceutical Technology

MARCH 22, 2023

The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MARCH 21, 2023

FDA and EMA decisions In January, the European Commission (EC) approved Roche’s Xofluza (baloxavir marboxil) to prevent and treat influenza in children ages one year and older. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Packaging 59

Packaging FDA Vaccines Labelling 59

Pharmaceutical Technology

FEBRUARY 6, 2023

These deductions include underwriting discounts and commissions and estimated offering expenses payable by pliant. However, elevated interest rates and increases in inflationary pressures contributed towards a significant reduction in the value and number of IPOs as companies were more wary of risky business decisions in 2022.

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 59

Pharmaceutical Technology

JUNE 22, 2023

In 2018, the Swedish Public Health Agency was commissioned by the government to test out a guaranteed reimbursement model. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Documentation 52

Documentation Communication 52

Pharmaceutical Technology

JANUARY 15, 2023

On December 5, the European Commission (EC) approved Amryt Pharma’s Mycapssa (octreotide), the only oral somatostatin analog indicated to treat acromegaly. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Labelling 52

Labelling Packaging FDA Communication 52

Pharmaceutical Technology

FEBRUARY 27, 2023

Source: GlobalData Pharmaceutical Intelligence Center On January 30, the European Commission approved Regeneron Pharmaceuticals’ and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE). GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Packaging 52

Packaging Chemotherapy FDA Labelling 52